Nitric oxide-induced activation of the AMP-activated protein kinase α2 subunit attenuates IκB kinase activity and inflammatory responses in endothelial cells

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Bess, Elke ^a   Fisslthaler, Beate ^a   Frömel, Timo ^a   Fleming, Ingrid ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMP ACTIVATED PROTEIN KINASE ALPHA2; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; NITRIC OXIDE; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MONOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

MUS;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL ADHESION; CERCOPITHECUS AETHIOPS; COS CELLS; E-SELECTIN; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; INFLAMMATION; MICE; NF-KAPPA B; NITRIC OXIDE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 79958078455     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020848     Document Type: Article

References (38)

1. Fisslthaler B, Fleming I, (2009) Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res 105: 114-127.
2. Arad M, Seidman CE, Seidman JG, (2007) AMP-activated protein kinase in the heart: role during health and disease. Circ Res 100: 474-488.
3. Boyle JG, Logan PJ, Ewart MA, Reihill JA, Ritchie SA, et al. (2008) Rosiglitazone stimulates nitric oxide synthesis in human aortic endothelial cells via AMP-activated protein kinase. J Biol Chem 283: 11210-11217.
4. Mount PF, Lane N, Venkatesan S, Steinberg GR, Fraser SA, et al. (2008) Bradykinin stimulates endothelial cell fatty acid oxidation by CaMKK-dependent activation of AMPK. Atherosclerosis 200: 28-36.
5. Zhang J, Xie Z, Dong Y, Wang S, Liu C, et al. (2008) Identification of nitric oxide as an endogenous activator of the AMP-activated protein kinase in vascular endothelial cells. J Biol Chem 283: 27452-27461.
6. Stahmann N, Woods A, Carling D, Heller R, (2006) Thrombin activates AMP-activated protein kinase in endothelial cells via a pathway involving Ca2+/calmodulin-dependent protein kinase kinase β. Mol Cell Biol 26: 5933-5945.
7. Li J, Coven DL, Miller EJ, Hu X, Young ME, et al. (2006) Activation of AMPK α- and γ-isoform complexes in the intact ischemic rat heart. Am J Physiol Heart Circ Physiol 291: H1927-H1934.
8. Fleming I, Fisslthaler B, Dixit M, Busse R, (2005) Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells. J Cell Sci 118: 4103-4111.
9. Fisslthaler B, Fleming I, Keserü B, Walsh K, Busse R, (2007) Fluid shear stress and NO decrease the activity of the hydroxy-methylglutaryl coenzyme A reductase in endothelial cells via the AMP-activated protein kinase and FoxO1. Circ Res 100: e12-e21.
10. Dixit M, Bess E, Fisslthaler B, Hartel FV, Noll T, et al. (2008) Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells. Cardiovasc Res 77: 160-168.
11. Webler AC, Michaelis UR, Popp R, Barbosa-Sicard E, Murugan A, et al. (2008) Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. Am J Physiol Cell Physiol 295: C1292-C1301.
12. Cacicedo JM, Yagihashi N, Keaney JF Jr, Ruderman NB, Ido Y, (2004) AMPK inhibits fatty acid-induced increases in NF-κB transactivation in cultured human umbilical vein endothelial cells. Biochem Biophys Res Commun 324: 1204-1209.
13. Okayasu T, Tomizawa A, Suzuki K, Manaka K, Hattori Y, (2008) PPARα activators upregulate eNOS activity and inhibit cytokine-induced NF-κB activation through AMP-activated protein kinase activation. Life Sci 82: 884-891.
14. Suzuki K, Uchida K, Nakanishi N, Hattori Y, (2008) Cilostazol activates AMP-activated protein kinase and restores endothelial function in diabetes. Am J Hypertens 21: 451-457.
15. Hattori Y, Nakano Y, Hattori S, Tomizawa A, Inukai K, Kasai K, (2008) High molecular weight adiponectin activates AMPK and suppresses cytokine-induced NF-κB activation in vascular endothelial cells. FEBS Lett 582: 1724.
16. Viatour P, Merville MP, Bours V, Chariot A, (2005) Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem Sci 30: 43-52.
17. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I, (2008) Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 28: 1368-1374.
18. Hattori Y, Suzuki K, Tomizawa A, Hirama N, Okayasu T, et al. (2009) Cilostazol inhibits cytokine-induced nuclear factor-κB activation via AMP-activated protein kinase activation in vascular endothelial cells. Cardiovasc Res 81: 133-139.
19. Wang C, Li L, Zhang ZG, Fan D, Zhu Y, et al. (2010) Globular adiponectin inhibits angiotensin II-induced nuclear factor kappaB activation through AMP-activated protein kinase in cardiac hypertrophy. J Cell Physiol 222: 149-155.
20. Tomizawa A, Hattori Y, Kasai K, (2009) Induction of gene expression in response to globular adiponectin in vascular endothelial cells. Life Sci 85: 457-461.
21. Bair AM, Thippegowda PB, Freichel M, Cheng N, Ye RD, et al. (2009) Ca2+ entry via TRPC channels is necessary for thrombin-induced NF-κB activation in endothelial cells through AMP-activated protein kinase and protein kinase Cδ. J Biol Chem 284: 563-574.
22. Liu C, Liang B, Wang Q, Wu J, Zou MH, (2010) Activation of the AMP-activated protein kinase α1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins BCL-2 and survivin. J Biol Chem 285: 15346-16355.
23. Wang S, Zhang M, Liang B, Xu J, Xie Z, et al. (2010) AMPKα2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo. Role of 26S proteasomes. Circ Res 106: 1117-1128.
24. Guigas B, Taleux N, Foretz M, Detaille D, Andreelli F, et al. (2007) AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside. Biochem J 404: 499-507.
25. Sun SC, Ganchi PA, Ballard DW, Greene WC, (1993) NF-κB controls expression of inhibitor IκBα: evidence for an inducible autoregulatory pathway. Science 259: 1912-1915.
26. Ho RC, Hirshman MF, Li Y, Cai D, Farmer JR, et al. (2005) Regulation of IκB kinase and NF-κB in contracting adult rat skeletal muscle. Am J Physiol Cell Physiol 289: C794-C801.
27. Chandrasekar B, Boylston WH, Venkatachalam K, Webster NJG, Prabhu SD, et al. (2008) Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-κB/PTEN suppression. J Biol Chem 283: 24889-24898.
28. Sag D, Carling D, Stout RD, Suttles J, (2008) Adenosine 5′-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 181: 8633-8641.
29. Delhase M, Hayakawa M, Chen Y, Karin M, (1999) Positive and negative regulation of IκB kinase activity through IKKκ subunit phosphorylation. Science 284: 309-313.
30. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R, (1995) Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76: 980-986.
31. Busse R, Lamontagne D, (1991) Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells. Naunyn Schmiedebergs Arch Pharmacol 344: 126-129.
32. World Medical Association (1997) World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Cardiovascular Research 35: 2-3.
33. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, et al. (2004) Knockout of the α2 but not α 5′-AMP-activated protein kinase isoform abolishes 5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle. J Biol Chem 279: 1070-1079.
34. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, et al. (2003) The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111: 91-98.
35. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, et al. (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20: 6704-6711.
36. Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, et al. (2005) Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54: 1331-1339 54/5/1331 [pii].
37. Schini-Kerth VB, Boese M, Busse R, Fisslthaler B, Mülsch A, (1997) N-α-tosyl-L-lysine chloromethylketone prevents expression of iNOS in vascular smooth muscle by blocking activation of NF-κB. Arterioscler Thromb Vasc Biol 17: 672-679.
38. Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, et al. (1998) Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases. Mol Cell Biol 18: 5157-5165.